 Cytokine Release Syndrome, CRS, is the leading side effect during chimeric antigen receptor, CAR, T-therapy. It also plays a critical role in viral infections such as coronavirus disease 2019, COVID-19, therefore, efficient removal of excessive cytokines is essential for treatment. This article was authored by Shalei Hao, David Jin, Shu Guang Zhong, and others.